The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Immune response to type III group B streptococcal polysaccharide-tetanus toxoid conjugate vaccine.
Open accessAbstract
Group B Streptococcus (GBS) is an important perinatal pathogen. Because transplacentally acquired maternal antibodies to the GBS capsular polysaccharides (CPS) confer protection, prevention of infant disease may be possible after immunization of women. Unfortunately, the purified CPS of GBS are only variably immunogenic in adults; therefore to enhance immunogenicity we have designed and developed a CPS-protein conjugate vaccine. The lability of a conformationally dependent epitope on the III CPS containing a critical sialic acid residue was important to consider in vaccine design. 100 women were randomized to receive GBS type III CPS-tetanus toxoid conjugate (III-TT) vaccine at one of three doses; unconjugated GBS type III CPS; or saline. Serum samples were obtained before immunization and 2, 4, 8, and 26 wk thereafter, and specific antibody to type III CPS was measured. Vaccines were well tolerated. In sera from recipients of the highest dose of III-TT, CPS-specific IgG levels rose from a geometric mean of 0.09 microg/ml before immunization to 4.53 microg/ml 8 wk later, whereas levels in recipients of unconjugated type III CPS rose from 0.21 microg/ml to 1.41 microg/ml. Lower doses resulted in lower antibody levels. A > or = 4-fold rise in antibody concentration was achieved in 90% of recipients of III-TT compared with 50% of those that received III CPS (P = 0.0015). Antibodies evoked by the conjugate vaccine recognized a conformationally dependent epitope of the III-CPS, promoted opsonophagocytosis and killing of GBS, and, after maternal immunization, protected neonatal mice from lethal challenge with type III GBS. We conclude that directed coupling of type III GBS polysaccharide to a carrier protein yielded a conjugate vaccine with preserved expression of a highly labile conformational epitope involving sialic acid and enhanced immunogenicity compared with uncoupled CPS.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Prevention of Perinatal Group B Streptococcal Disease: A Public Health Perspective: (547302006-001)
(1996) · PsycEXTRA Dataset · doi:10.1037/e547302006-001 · Cited by 709
Baker, C. J., & Kasper, D. L. (1976) · New England Journal of Medicine · doi:10.1056/nejm197604012941404 · Cited by 671
Self-citationA Population-Based Assessment of Invasive Disease Due to Group B Streptococcus in Nonpregnant Adults
Farley, M. M., Harvey, C., Stull, T., Smith, J. D., Schuchat, A., Wenger, J. D., & Stephens, D. S. (1993) · New England Journal of Medicine · doi:10.1056/nejm199306243282503 · Cited by 496
Group B Streptococcal Infections
Baker, C. J. (1997) · Clinics in Perinatology · doi:10.1016/s0095-5108(18)30184-2 · Cited by 433
Self-citationLancefield, R. C., McCarty, M., & Everly, W. (1975) · The Journal of Experimental Medicine · doi:10.1084/jem.142.1.165 · Cited by 365
Immunization of Pregnant Women with a Polysaccharide Vaccine of Group B Streptococcus
Baker, C. J., Rench, M. A., Edwards, M. S., Carpenter, R. J., Hays, B. M., & Kasper, D. L. (1988) · New England Journal of Medicine · doi:10.1056/nejm198811033191802 · Cited by 296
Self-citationRisk Factors for Group B Streptococcal Disease in Adults
Jackson, L. A., Hilsdon, R., Farley, M. M., Harrison, L. H., Reingold, A. L., Plikaytis, B. D., Wenger, J. D., & Schuchat, A. (1995) · Annals of Internal Medicine · doi:10.7326/0003-4819-123-6-199509150-00003 · Cited by 263
Guidelines for Prevention of Group B Streptococcal (GBS) Infection by Chemoprophylaxis
Committee on Infectious Diseases and Committee on Fetus and Newborn (1992) · Pediatrics · doi:10.1542/peds.90.5.775 · Cited by 255
Epidemiology of Group B Streptococcal Disease
Schuchat, A., & Wenger, J. D. (1994) · Epidemiologic Reviews · doi:10.1093/oxfordjournals.epirev.a036159 · Cited by 205
Wessels, M. R., Paoletti, L. C., Kasper, D. L., DiFabio, J. L., Michon, F., Holme, K., & Jennings, H. J. (1990) · Journal of Clinical Investigation · doi:10.1172/jci114858 · Cited by 191
Self-citationCombining Dependent Tests with Incomplete Repeated Measurements
Wei, L. J., & Johnson, W. E. (1985) · Biometrika · doi:10.2307/2336088 · Cited by 188
Multistate case-control study of maternal risk factors for neonatal Group B streptococcal disease
SCHUCHAT, A., DEAVER-ROBINSON, K., PLIKAYTIS, B. D., ZANGWILL, K. M., MOHLE-BOETANI, J., & WENGER, J. D. (1994) · The Pediatric Infectious Disease Journal · doi:10.1097/00006454-199407000-00008 · Cited by 182
Role of Antibody to Native Type III Polysaccharide of Group B Streptococcus in Infant Infection
Baker, C. J., Edwards, M. S., & Kasper, D. L. (1981) · Pediatrics · doi:10.1542/peds.68.4.544 · Cited by 181
Self-citationCombining dependent tests with incomplete repeated measurements
WEI, L. J., & JOHNSON, W. E. (1985) · Biometrika · doi:10.1093/biomet/72.2.359 · Cited by 177
Mohle‐Boetani, J. C. (1993) · JAMA · doi:10.1001/jama.270.12.1442 · Cited by 153
Jennings, H. J., Ługowski, C., & Kasper, D. L. (1981) · Biochemistry · doi:10.1021/bi00519a001 · Cited by 115
Self-citationEnglund, J. A., Glezen, W. P., Turner, C., Harvey, J., Thompson, C. M., & Siber, G. R. (1995) · The Journal of Infectious Diseases · doi:10.1093/infdis/171.1.99 · Cited by 102
Wessels, M. R., Paoletti, L. C., Rodewald, A. K., Michon, F., DiFabio, J., Jennings, H. J., & Kasper, D. L. (1993) · Infection and Immunity · doi:10.1128/iai.61.11.4760-4766.1993 · Cited by 98
Self-citationThe Reverse Cumulative Distribution Plot: A Graphic Method for Exploratory Analysis of Antibody Data
Reed, G. F., Meade, B. D., & Steinhoff, M. C. (1995) · PEDIATRICS · doi:10.1542/peds.96.3.600 · Cited by 98
Paoletti, L. C., Kasper, D. L., Michon, F., Fábio, J. L. D., Jennings, H. J., Tosteson, T. D., & Wessels, M. R. (1992) · Journal of Clinical Investigation · doi:10.1172/jci115564 · Cited by 77
Self-citationQuantitative Determination of Antibodies to Type III Group B Streptococcal Polysaccharide
Guttormsen, H., Baker, C. J., Edwards, M. S., Paoletti, L. C., & Kasper, D. L. (1996) · The Journal of Infectious Diseases · doi:10.1093/infdis/173.1.142 · Cited by 69
Self-citationNeonatal Mouse Model of Group B Streptococcal Infection
Rodewald, A. K., Onderdonk, A. B., Warren, H. B., & Kasper, D. L. (1992) · The Journal of Infectious Diseases · doi:10.1093/infdis/166.3.635 · Cited by 67
Self-citationSynthetic Glycoconjugates as Human Vaccines
Jennings, H. J., & Sood, R. K. (1994) · Elsevier eBooks · doi:10.1016/b978-0-12-440585-1.50013-9 · Cited by 52
Self-citationStatXact: A Statistical Package for Exact Nonparametric Inference
Mehta, C. R. (1991) · The American Statistician · doi:10.2307/2685246 · Cited by 39
Häyrinen, J., Pelkonen, S., & Finne, J. (1989) · Vaccine · doi:10.1016/0264-410x(89)90232-6 · Cited by 11
Cited by
Bacterial Meningitis in the United States in 1995
Schuchat, A., Robinson, K., Wenger, J. D., Harrison, L. H., Farley, M., Reingold, A. L., Lefkowitz, L., & Perkins, B. A. (1997) · New England Journal of Medicine · doi:10.1056/nejm199710023371404 · Cited by 1,251
Epidemiology of Invasive Group B Streptococcal Disease in the United States, 1999-2005
Phares, C. R. (2008) · JAMA · doi:10.1001/jama.299.17.2056 · Cited by 878
Epidemiology of Group B Streptococcal Disease in the United States: Shifting Paradigms
Schuchat, A. (1998) · Clinical Microbiology Reviews · doi:10.1128/cmr.11.3.497 · Cited by 609
Prevention of Perinatal Group B Streptococcal Disease: (548432006-001)
(2002) · PsycEXTRA Dataset · doi:10.1037/e548432006-001 · Cited by 554
Schuchat, A. (1999) · The Lancet · doi:10.1016/s0140-6736(98)07128-1 · Cited by 386
Metadata
- Authors
- Kasper, D. L., Paoletti, L. C., Wessels, M. R., Guttormsen, H. K., Carey, V. J., Jennings, H. J., & Baker, C. J.
- Venue
- Journal of Clinical Investigation
- Published
- 1996-11-15
- Volume
- 98
- Issue
- 10
- Pages
- 2308-2314
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W1972420743
- Cited by
- 264
- References
- 25
- FWCI
- 18.58
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.